Effective treatment for chronic infections is undermined by a significant gap in understanding of the physiological state of pathogens at the site of infection. Chronic pulmonary infections are responsible for the morbidity and mortality of millions of immunocompromised individuals worldwide, yet drugs that are successful in laboratory culture are far less effective against pathogen populations persisting in vivo. Laboratory models, upon which preclinical development of new drugs is based, can only replicate host conditions when we understand the metabolic state of the pathogens and the degree of heterogeneity within the population. In this study, we measured the anabolic activity of the pathogen Staphylococcus aureus directly in the sputum of pediatric patients with cystic fibrosis (CF), by combining the high sensitivity of isotope ratio mass spectrometry with a heavy water labeling approach to capture the full range of in situ growth rates. Our results reveal S. aureus generation times with a median of 2.1 d, with extensive growth rate heterogeneity at the single-cell level. These growth rates are far below the detection limit of previous estimates of CF pathogen growth rates, and the rates are slowest in acutely sick patients undergoing pulmonary exacerbations; nevertheless, they are accessible to experimental replication within laboratory models. Treatment regimens that include specific antibiotics (vancomycin, piperacillin/tazobactam, tobramycin) further appear to correlate with slow growth of S. aureus on average, but follow-up longitudinal studies must be performed to determine whether this effect holds for individual patients.
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slow growth | infectious disease | metabolic heterogeneity | cystic fibrosis | hydrogen isotope labeling G rowth rate is arguably the simplest yet most profound phenotypic parameter that defines microbial existence. It integrates multiple aspects of a cell's physiological state, and is often correlated with how cells respond to challenges presented by diverse stressors, including the immune system and antimicrobial drugs (1) (2) (3) (4) . Despite recognition that growth rate impacts microbial persistence, very few direct measurements of in vivo generation times exist, in large part because quantifying this parameter within a complex environment presents considerable technical challenges. Chronic infections are often assumed to comprise dormant pathogens, but whether they are truly dormant or merely growing slowly is unknown.
In this study, we focused our attention on the microbial populations within the lungs of patients with cystic fibrosis (CF). CF patients expectorate infected mucus daily, making the in vivo environment directly accessible to experimental investigation. Few prior estimates of microbial growth rates exist for CF sputum (5) (6) (7) . These estimates are based on detecting the ribosomal RNA (rRNA) content of bacterial cells using fluorescence in situ hybridization (FISH). Kragh et al. (6) , for example, showed that the majority of Pseudomonas aeruginosa cells in explanted CF lung samples display similar amounts of rRNA to cells in stationary phase, with an rRNA content below that detected for cells in the slowest exponentially growing batch cultures (∼0.35 divisions per hour). Although fluorescence intensity can assess growth when the cellular generation time is faster than ∼3 h, use of rRNA abundance as a quantitative proxy for slow growth in dynamically changing environments is limited because rRNA content can become completely decoupled from growth (8) . This fundamental biological constraint necessitates a new approach to measuring in vivo growth rates.
Utility of Highly Sensitive Stable Isotope Tracers for Application in the Human Host
Stable isotope tracers (e.g., 13 C, 2 H, and 15 N) have been used by geobiologists to study the growth and metabolism of slowly growing microbial populations in poorly accessible and energy-limited habitats at the seafloor (9, 10) , and in the deep biosphere (11) .
Unlike methods that count cells or particular biomolecules, isotope tracer methods can reveal growth rates that reflect population biosynthetic activity regardless of whether the population is expanding, at steady state, or declining. Isotopic enrichments thus provide a measure of biosynthetic turnover that is independent of total biomass (Fig. 1A) , making their use wellsuited to studies of infected human specimens like CF sputum, where the size of the population can vary due to interactions with other pathogens and the host immune system. Here, we used heavy water ( 2 H 2 O) because of its advantages as a chemically and nutritionally passive isotope tracer when used at subtoxic concentrations, and measured 2 H incorporation into microbialspecific fatty acids by gas chromatography/pyrolysis/isotope ratio Significance A major challenge in treating chronic infections is the lack of insight into microbial survival mechanisms in vivo. Many drugs require cells to be doubling rapidly to have their greatest effect, yet the in vivo pathogen growth rate is largely unknown. By labeling freshly expectorated mucus from cystic fibrosis patients with heavy water, we found that the effective growth rates of Staphylococcus aureus are at least two orders of magnitude slower, on average, than typically studied in the laboratory, and are extremely heterogeneous at the single-cell level. These findings underscore the need to study slow growth physiology to gain insight into pathogen survival mechanisms, motivated by the hope that such insight will ultimately help improve drug design and clinical outcomes. Our aim in this study was to develop a method to quantify average and single-cell growth rates for pathogens in chronic infections. For this purpose, we targeted measuring the growth rate of Staphylococcus aureus in CF sputum as a proof of principle. Although CF infections are polymicrobial and compositionally diverse, some bacterial species are common (16) . S. aureus is one of the earliest and most prevalent bacteria detected in infants and children with CF, and has garnered attention in the last decade due to the rise of beta-lactam-resistant strains (methicillinresistant S. aureus, or MRSA) (17) . We therefore sought to measure the growth rate of S. aureus within freshly expectorated CF sputum both at the population and single-cell level. This approach has the potential to be extended to quantify slow growth rates of diverse organisms in many contexts, ranging from infectious diseases to industrial fermentations to the deep subsurface.
Approach: Methods, Calculations, and Controls To confidently estimate the in vivo growth rate using an isotope labeling method, a number of factors must be taken into consideration. These include identification of an appropriate biological target molecule, controls to confirm biological compatibility of the isotope label, access of the label to the sample, determination of the extent of label incorporation into the target molecule during biosynthesis, and estimation of how much anabolic activity can be attributed to growth vs. maintenance. Fig. 2 presents an overview of all aspects of our approach and highlights the relevant figures for each step.
Identifying an appropriate biological target for analysis is of primary importance, and several biological considerations must be kept in mind (Fig. 2, marked in green) . S. aureus synthesizes specific fatty acids (the anteiso methyl branched C 14 and C 16 saturated fatty acids, hereafter referred to by their total carbon numbers as a-C 15:0 and a-C 17:0 , respectively) that can be distinguished from the human host and most other dominant CF pathogens (Fig. S1) , and which are synthesized de novo without recycling (Fig. S2) . The lack of fatty acid recycling by S. aureus is a critical aspect for our quantitative approach: If organisms build the targeted lipids from exogenous fatty acids, the amount of 2 H incorporated from heavy water would be greatly reduced and therefore underestimate population growth rates. By targeting specifically a-C 15:0 and a-C 17:0 for isotopic analysis, we could focus on a suitable marker for S. aureus. Because heavy water can be toxic at high concentrations (18) (Fig. S3) . For the isotope labeling of clinical samples (Fig. 2, expectoration, and incubated at 37°C for up to 60 min for bulk growth rate measurements, and up to 2 h for single-cell analyses. These relatively short incubation times were selected to preserve the in situ sputum environment (19) as closely as possible during the tracer incubation, while still ensuring long enough exposure to the isotope label to allow for measurable incorporation into slow-growing populations. The resulting isotopic enrichment from growth of S. aureus in the presence of the 2 H-spiked water was then used to model the apparent growth rate of the pathogen, taking into consideration several potentially confounding factors (Fig. 2, marked in gold) . The first concerns the noninstantaneous penetration of the isotope label into a clinical sample. On the time scale of long environmental incubations lasting days or months, the time it takes for heavy water to mix into the sample would be negligible, but, due to the short incubation time (∼1 h), this effect becomes relevant, and we parametrized the mixing rate empirically by using isotope label equilibration times in clinical samples (Fig.  S4 ). The second concerns the hydrogen metabolism of S. aureus during fatty acid biosynthesis. Although newly synthesized fatty acids follow the isotopic composition of water, this is generally not a 1:1 relationship, because of enzymatic kinetic isotope effects during biosynthesis and because not all H atoms are derived from water during heterotrophic growth. The appropriate value for the resulting water hydrogen assimilation by S. aureus growing in clinical samples was determined experimentally in synthetic CF sputum medium (SCFM) (20) following previously established methods (21) (Fig. S5 ). Finally, because our approach captures the overall anabolic activity, including both the specific growth rate (which signifies true cellular replication) and the maintenance turnover rate (which describes biosynthesis in excess of growth to compensate for degradation and material turnover), quantifying growth requires constraints on the maintenance contribution. We thus grew S. aureus in chemostat culture at a controlled, slow growth rate of 0.14 divisions per day (doubling time of 4.9 d) in SCFM, and measured 2 H incorporation after a 2 H 2 O spike to approximate the contribution of maintenance turnover to fatty acid 2 H uptake (Fig. S6 ). Using these constraints, we could infer the apparent growth rate of S. aureus in clinical samples by numerically fitting the clinical data ( 2 F fa and 2 F w , the fractional isotope abundances of 2 H measured in fatty acids and sputum water, respectively) to the following equation (full derivation in Supporting Information):
This takes into consideration the aforementioned incorporation of hydrogen from water by S. aureus (a ω ), rate of label exchange with the mucus (k), and turnover rate (ω). Uncertainties associated with these parameters are discussed in Supporting Information (Fig. S7) . It is important to note that if the chemical environment within the sputum requires even higher relative rates of fatty acid maintenance/repair than the chemically stable environment of the chemostat, the clinical growth rates would be even lower than currently estimated.
Results and Discussion
Growth Rates of S. aureus Populations in Clinical Samples. Having performed these control experiments, we set out to collect a robust cross-sectional dataset from CF patients. Fig. 3 displays the average growth rate of S. aureus populations in 37 samples from 16 patients. The growth rate range for each sample is constrained by the a-C 15:0 and a-C 17:0 S. aureus specific fatty acid isotope enrichments, and the average rates are calculated from their mass balance. Major potential contributions to these specific fatty acids by other organisms (e.g., Stenotrophomonas maltophilia, Fig. S1 ) were ruled out on the basis of 16S rRNA gene sequencing, which indicated that Staphylococcaceae were far more abundant (54% on average, Table S1 ) than the entire family of Xanthomonadaceae to which Stenotrophomonas belongs (0.4%). Although the calculated in vivo growth rates of S. aureus vary between patients and even between samples from a single patient, all values are 2-100 times lower than the rates at which this organism is typically grown in the laboratory (22) . The slow average growth rates suggest that S. aureus populations experience environmental constraints within the lung environment. Unlike in many aquatic environments in nature, carbon and nitrogen limitations are less likely to occur within the organic-rich CF sputum environment where millimolar concentrations of free amino acids and other potential nutrient sources have been measured (20) . Research into the in situ concentrations and limits of oxygen penetration in sputum points to oxygen availability as a likely dominant growth constraint (19, 23) , in addition to inhibition by microbial competitors in the polymicrobial environment (24) , as well as effects from continuous antibiotic treatment in these patients and the activity of the immune system (6) . Future work in a more expansive longitudinal study of sputum samples artificially amended with different nutrients and antibiotics will help shed light on the factors restricting pathogen growth. Table S1 for details.) Separate column (chemostat) shows a representative growth rate from a chemostat culture of S. aureus (Fig. S6 ), demonstrating that it is possible to model slow clinically relevant growth rates in the laboratory. Area highlighted in blue represents the typical range of growth rates studied in laboratory experiments with S. aureus.
The data in Fig. 3 also reveal a systematically higher 2 H enrichment of a-C 15:0 over a-C 17:0 fatty acids that is more pronounced than the equivalent pattern observed for S. aureus grown in chemostat culture in SCFM. Interestingly, S. aureus appears to shift its membrane fatty acid composition in response to slower growth (Fig. S8) , a phenomenon also observed in other microorganisms (e.g., refs. 25 and 26) . This could explain the systematically higher 2 H enrichment of a-C 15:0 if substantial heterogeneity exists in the underlying staphylococcal population, with slower-growing cells preferentially producing a-C 17:0 and faster-growing cells producing more a-C 15:0 .
Heterogeneity of Microbial Activity. To test the hypothesis that substantial population heterogeneity exists, we used FISH coupled to secondary ion mass spectrometry (FISH-NanoSIMS) to measure isotope incorporation at the single-cell level (27) . Growth rates from single-cell 2 H enrichments were calculated by converting thinsection NanoSIMS measurements to corresponding bulk membrane enrichments (details in Supporting Information). Fig. 4A shows representative FISH-NanoSIMS images for two cell clusters, illustrating the potential for significantly different in vivo single-cell growth activities on a small scale. The cluster on the left did not incorporate 2 H above background, indicating that the cells were dormant or dead, whereas the cluster on the right incorporated a large amount of 2 H within the 2-h incubation. In this visual field, clusters are microbial (identified by the bacterial FISH probe EUB338), but neither contains S. aureus cells.
For the quantitative NanoSIMS analysis shown in Fig. 4B , however, we targeted cells that hybridized specifically with an S. aureus FISH probe (28) . The abundance of Staphylococcaceae in the patients whose sputum was analyzed by NanoSIMS ranged from 42 to 56% (Table S1 ). The smoothed density distribution of the aggregated single-cell growth rates is illustrated for all measured S. aureus cells per patient sample. We observed substantial growth rate heterogeneity in all measured samples, with a particularly wide, apparently bimodal distribution observed in the third sample. Sample 4 also contained a large number of unidentified bacteria that were neither S. aureus nor P. aeruginosa, and appear to be consistently more active than the cooccurring S. aureus population (potential candidates from 16S data include members of the Moraxellaceae and Erythrobacteraceae, with sequence abundances of 13% and 9%, respectively). That S. aureus and other bacteria exhibit heterogeneous metabolic activity in vivo is consistent with a growing body of literature documenting the importance of heterogeneity in a wide range of systems (29) (30) (31) . Moreover, this heterogeneity may help explain why antibiotic treatments are not fully effective: If a reservoir of slowly growing cells exists for any bacterial species being targeted by antibiotics whose efficacy requires fast growth rates, it is not surprising that 25% of pulmonary exacerbations fail to recover to baseline health after treatment with i.v. antibiotics (32) .
Correlation with Clinical Parameters. Despite this heterogeneity, we asked whether the average growth rate of S. aureus in CF sputum correlates with particular host characteristics and clinical metrics. There were no significant relationships between S. aureus growth rates and host age, sex, body mass index (BMI), or lung function (as measured by forced expiratory volume FEV1%) nor with the community abundance of Staphylococcaceae or presence of the pathogen P. aeruginosa (Table 1) . Unexpectedly, S. aureus activity showed a statistically significant positive correlation with the day of the patient's hospital stay (i.e., higher apparent growth rates the longer a patient had been in the hospital) with a transient decrease in growth rates early on. Additionally, S. aureus populations show significantly higher growth rates in samples from patients who were well (pulmonary function at baseline) compared with samples from patients who were acutely sick (suffering a pulmonary exacerbation; Fig. 3 and Fig. S9) .
Intriguingly, on average, S. aureus growth rates were significantly lower when patients were taking the antibiotics vancomycin, piperacillin/tazobactam, or tobramycin at the time of sampling compared with when patients were not taking the respective antibiotic (Table 1 and Fig. S10 ), but no statistically significant trends were observed for the antibiotics aztreonam, colistin, and moxifloxacin. Although tobramycin is primarily used against P. aeruginosa, both piperacillin/tazobactam and vancomycin have antistaphylococcal activity. We also note, however, that we were unable to determine whether these correlations held statistical significance for individuals, due to the limited number of patient-specific longitudinal samples (Fig. S10) . Generally, at the individual level, being on any antistaphylococcal antibiotics at the time of sampling exhibited no clear trend with respect to growth rate (Fig. 3) . Intriguingly, the growth rate of S. aureus in some patients at the beginning of their hospital stay appeared to slow, with a return to baseline well before discontinuation of the treatment (e.g., red and teal, Fig. 3 ). Such dynamics make it tempting to speculate that early during a hospital stay, treatment with anti-Staph antibiotics depresses S. aureus growth rates, yet, because patients are simultaneously given many drugs that target various members of microbial community, as other bacteria are eradicated over time, S. aureus experiences resource expansion and/or reduced antagonism and begins to grow more quickly. We emphasize, however, that this speculative interpretation requires testing in dedicated longitudinal studies where multivariable regression models can help parse out the interplay between health indicators, treatment regimen, and pathogen growth rate.
Conclusions. Our studies of S. aureus in CF sputum reveal that pathogen growth rates can be far slower and more heterogeneous in human infections than previously assumed. Nevertheless, the A B range of growth rates that we observe here is largely accessible to experimental replication within laboratory models. Understanding metabolic diversity during slow growth, and how this impacts survival strategies for microorganisms, is a poorly developed but fundamental aspect of microbial physiology and ecology in any environment. What strategies do cells take to control core processes such as transcription, translation, and membrane integrity when persisting in a slow growth mode? How different are these strategies from those that promote cellular homeostasis when nutrients are plentiful and growth is fast? The answers to these and other questions in the context of pathogen behavior in chronic infections are important to understand for practical reasons. For example, Mycobacterium tuberculosis is known to persist under hypoxic, nonreplicating conditions (33); encouragingly, inhibition of membrane components that contribute to electron transport and/or proton translocation under these conditions shows promise for shortening the time of tuberculosis therapy (34, 35) . Ultimately, a better understanding of how populations grow in vivo is crucial to developing representative in vitro tests of potential therapies for diverse pathogens that infect the human host (36) .
Materials and Methods
Study Design. All patients were recruited from CHLA and gave informed consent or assent in accordance with IRB CCI-13000211. Inclusion criteria were a positive diagnosis of CF, ability to expectorate sputum, and recent detection of an infection by S. aureus from clinical data.
Sample Collection. Immediately upon expectoration (within 5-10 min), sputum samples were suspended at the hospital in a prewarmed PBS isotope labeling solution (with 1-30% vol/vol 2 H 2 O), and incubated at 37°C for up to 60 min. Microbial growth activity in samples for lipid analysis was arrested by flash-freezing in liquid nitrogen at the end of sample incubation, and samples were preserved at −80°C. Typically, most pediatric patients could not expectorate more than 0.5-1 g of sputum, but when sufficiently large sputum samples (>0.6 g) were expectorated, the sample was divided before isotope labeling with a scalpel or by transfer with a large syringe. Samples for single-cell analysis were treated the same as bulk samples, except for extension of incubation times up to 2 h (with 10-15% 2 H 2 O), and arrest of microbial activity at the end of incubation by transfer to a freshly thawed 1% formaldehyde solution in PBS. Just before sample preservation, the residual labeling solution was collected and filter-sterilized for water isotope analysis. Water Isotope Analysis. The water hydrogen isotopic composition ( 2 F w ) of all samples was measured using a Los Gatos Research DLT-100 liquid water isotope analyzer. Samples were analyzed in at least three replicate analyses with 10 injections each. Samples close to natural abundance isotopic composition were calibrated against four working standards (δ 2 H values: −117‰, −11‰, +290‰, +1,270‰) that in turn were calibrated against the VSMOW, GISP, and SLAP international standards (38) . Heavily enriched samples from isotope tracer solutions were beyond the linear response range of the instrument and were analyzed by dilution with water of known isotopic composition.
Fatty Acid Analysis. Frozen sputum samples were lyophilized for at least 48 h. Homogenized dry powder was weighed into ∼ 40-mg aliquots (or the maximum available amount), and spiked with 10 μg 21:0 phosphatidyl choline as a phospholipid extraction standard. Samples were transesterified in the presence of a base catalyst (0.5M NaOH in anhydrous methanol) at room temperature for 10 min (39). Free fatty acids and aldehydes are not esterified under basic conditions, which prevents the derivatization of fatty acids from degraded materials in the sputum sample, as well as the derivatization of abundant aldehydes, which interfere chromatographically with target analytes. Derivatized fatty acid methyl esters (FAMEs) were extracted into hexane, and concentrated under a stream of N 2 at room temperature. Because primary target analytes (a-C 15:0 FA and a-C 17:0 FA) typically constituted less than 1% of host-derived fatty acids, the high abundance of host material [primarily C 18:1 FA, C 18:2 FA, and longer chain (poly)-unsaturated fatty acids] interfered with compound-specific isotope ratio analysis of these compounds due to column overload. The low total amount of target analytes available from most sample sizes precluded the use of elaborate purification steps with low yields or risk of contamination. To remove several major host compounds and increase relative abundance of the analytes sufficiently for isotope ratio analysis, saturated (for binary parameters) or Spearman rank analysis. Spearman's P < 0 indicates positive correlation (i.e., faster growth rate with increase of the clinical parameter), and P < 0 indicates a negative correlation. See Table S1 for all data, and see Figs. S7 and S8 for correlation plots. Only antibiotics with at least five samples in each category (yes/no) were analyzed. -P > 0.05, *P ≤ 0.05, **P ≤ 0.01. † Evaluated by MWW test for binary parameters (sex, pulmonary exacerbation, and P. aeruginosa presence; each was evaluated for both alternative hypotheses; the most statistically significant alternative is given) and by Spearman rank analysis for all other parameters. ‡
The presence of P. aeruginosa was tested in routine clinical selective plating screens. The abundance of Staphylococcaceae was assessed by 16S rRNA gene sequencing. § Vancomycin is used against Gram-positive pathogens including MRSA; piperacillin/tazobactam is used against P. aeruginosa and some S. aureus (not effective against MRSA); tobramycin, aztreonam, and colistin are mostly used against P. aeruginosa; moxifloxacin is a broad-spectrum antibiotic mostly used against mycobacteria.
FAMEs were separated from unsaturated FAMEs using Discovery Ag-Ion solidphase extraction columns in combusted glass cartridges (Supelco; custom preparation to avoid contaminants from plastic columns). Extracted samples were dried to 1 mL and applied to preconditioned columns, followed by elution of saturated FAMEs in 0.125% acetone in hexane, and monosaturated and disaturated FAMEs in acetone. Separation of unsaturated and saturated fatty acids was quantitative using this procedure. Fractions were evaporated to dryness and resuspended in hexane before analysis.
FAMEs were analyzed by gas chromatography/mass spectrometry (GC/MS) on a Thermo-Scientific Trace DSQ equipped with a ZB-5ms column (30 m × 0.25 mm i.d., film thickness 0.25 μm) and PTV injector operated in splitless mode, using He as a carrier gas at 0.8 mL/min. The GC oven was held at 80°C for 1 min, ramped at 20°C/min to 130°C, and ramped at 5°C/min to a final temperature of 320°C (held for 20 min). Peaks were identified by comparison of mass spectra and retention times to authentic standards and library data. Fatty acids are referred to using the nomenclature z-C x:y , where x is the total number of carbons in the fatty acid skeleton (regardless of structure), y is the number of double bonds, and z-is a prefix describing additional structural features of the compound. The position and stereochemistry of the double bonds or cyclopropyl rings was not determined. The isotopic composition of the primary target analytes was measured in the saturated FAME fraction by GC/pyrolysis/isotope-ratio mass spectrometry on a ThermoScientific Delta + XP with methane of known isotopic composition as the calibration standard. A multicompound FAME standard was run every four to six samples to verify instrument accuracy and precision. Chromatographic conditions were identical to those from GC/MS analysis except for a thickfilm column (ZB-5ms, 30 m × 0.25 mm i.d., film thickness 1.00 μm) and slight modifications to the temperature program to optimize chromatographic separation of i-C 15:0 and a-C 15:0 /i-C 17:0 and a-C 17:0 despite peak broadening from isotope labeling and heavy column loading. Samples were injected in highly concentrated aliquots to obtain maximum signal for target analytes. Peaks were identified based on retention order and relative height based on the GC/MS analysis. High-abundance components in the saturate fraction (C 16:0 , C 18:0 , C 20:0 ) that were too concentrated relative to target analytes were prevented from entering the source by appropriately timed backflush of the column effluent. Relative proportions of fatty acids for isotope mass balance calculations were determined from peak areas corrected for derivatization and isotopic composition.
Single-Cell Analysis. Immediately upon receipt of samples from the hospital, formaldehyde-fixed sputum samples were transferred to excess PBS solution (10 mL) in a column above an 8-μm sterile filer. The sample was washed by slowly rinsing it with a total of 50 mL PBS solution that was added to the column in 10-mL aliquots and drained by gravimetric or slight vacuum flow through the filter. Samples were suspended in drops of molten noble agar [2% (wt/vol) Difco Agar Noble in 50 mM Hepes buffered filter-sterilized water], solidified by cooling at room temperature, and cut into ∼ 2-mm 3 cubes. Fixed and washed agar cubes were incubated for at least 1 h at 30°C in freshly prepared 1mg/mL lysozyme and 50 μg/mL lysostaphin (L2898; Sigma-Aldrich) in 10 mM Tris buffered water to digest S. aureus cell wall, washed once in PBS, resuspended in 50% (vol/vol) ethanol in PBS, and dehydrated in 100% ethanol over the course of three exchanges, with final resuspension in 100% for at least 1 h. Ethanol was then replaced twice with 100% Technovit 8100 infiltration solution (64709012; Heraeus Kulzer GmbH) to infiltrate the agar cubes overnight. Agar cubes were finally suspended in airtight 0.6-mL microcentrifuge tubes in Technovit 8100 infiltration solution amended with hardener II reagent and stored at 4°C for overnight polymerization. Thin sections (1 μm thick) were cut using a rotary microtome. Each section was stretched on the surface of a water drop on polylysine-coated microscope slides and air-dried at room temperature.
FISH was conducted on the plastic thin sections using the universal bacterial probe EUB338 [5′ to 3′: GCT GCC TCC CGT AGG AGT (40) ], which hybridizes to bacterial 16S rRNA, probe Sau [5′ to 3′: GAA GCA AGC TTC TCG TCC G (28)], which hybridizes to S. aureus 16S rRNA, and probe Psae [5′ to 3′: TCT CGG CCT TGA AAC CCC (41)], which hybridizes to P. aeruginosa 23S rRNA. Both probes were specifically designed and tested for use in microbial identification in CF sputum (41, 42) . Additionally, probe Non338 [5′ to 3′: ACT CCT ACG GGA GGC AGC (43) ], an oligonucleotide complementary to the probe EUB338, served as a negative control for nonspecific binding. Probes EUB338 and Non338 were labeled with the cyanine dye Cy3, probe Sau were labeled with the cyanine dye Cy5, and probe Psae were labeled with fluorescein. All probes were labeled on both the 5′ and 3′ end to increase fluorescence intensity (44) . For hybridization, each section was covered with 20 μl of hybridization buffer [0.9 M NaCl, 20mM Tris·HCl at pH 8, 0.01% SDS, 20% (vol/vol) formamide (28, 42) ] containing 50 ng of unlabeled oligonucleotide probe BET42a [5′ to 3′: GCC TTC CCA CTT CGT TT (45)] and preincubated for 10 min at 46°C to reduce nonspecific binding of labeled oligonucleotide probes (41) . Probes EUB338 (or Non338), Sau, and Psae were added (5 ng/μL), and samples were incubated in a moisture chamber at 46°C for 3 h. Stringent washing was performed by incubating the samples in washing buffer at decreased NaCl concentration [225 mM NaCl with 5 mM EDTA, 20 mM Tris·HCl at pH 8, 0.01% SDS (46) ] at 48°C for 12 min. Finally, samples were dipped into ice-cold deionized water to rinse off the salt, air-dried, and mounted in the glycerol-based soft mount Vectashield (Vector Laboratories) (47) with 1.5 μg/mL 4′,6-diamidino-2-phenylindole (DAPI) as a DNA counterstain. Samples were routinely imaged using a Zeiss Axio Imager microscope, and mapped extensively for sample identification and target localization for FISH−NanoSIMS using a Keyence BZ-9000 microscope equipped with a mercury lamp and filter cubes for DAPI, GFP, Cy3, and Cy5. For secondary ion mass spectrometry, samples were made conductive by sputter-coating with a 50-nm layer of gold.
All samples were analyzed with a CAMECA NanoSIMS 50L (CAMECA) housed in the Division of Geological and Planetary Sciences at California Institute of Technology. Cells in plastic thin sections were analyzed using a 1.9-to 3.6-pA primary Cs + beam, and were presputtered with a ∼ 200-pA primary Cs + beam current (I pre ) for 3-15 min (t), depending on the size of the presputtering area (A), to a cumulative charge density of ∼ 30 pC/μm 2 (I pre · t=A).
Seven masses were collected in parallel ( areas. Presputtering was carried out on a region larger than the analytical frame by at least 2 μm on each side. Analytical parameters including primary beam focus, secondary beam centering, and mass resolution for all ions were verified every ∼ 30 min. To correct for instrument mass fractionation and matrix effects of the plastic polymer, we calibrated plastic-embedded singlecell measurements against bacterial isotope standards that were analyzed at the same time and were previously presented in detail (27) . Data evaluation is discussed in more detail in Supporting Information.
The 16S Ribosomal RNA Gene Sequencing. DNA was prepared from ∼1 mg lyophilized sputum samples treated with 2% vol/vol PBS/β-mercapto-ethanol for 2 h at room temperature and Sputolysin (Calbiochem) for 30 min at 37°C, followed by lysis in 180 μL of buffer ATL (Qiagen Blood and Tissue DNeasy kit) amended with lysostaphin (final concentration 0.14 mg/mL) and lysozyme (final concentration of 2.9 mg/mL) (48) for 2 h at 37°C, beadbeating with 0.1-mm glass beads for 10 min, and extraction using the Qiagen Animal Tissues Spin Column Protocol with 20 μL proteinase K during overnight incubation. High throughput sequencing was performed as previously described (49) . Briefly, purified DNA was amplified in triplicate using 16S rRNA Illumina barcoded primers specific to the V4 region of the 16S rRNA gene. Samples were pooled, and paired-end sequencing was performed on an Illumina MiSeq platform at CHLA. Sequences were demultiplexed and trimmed, and paired-end reads were joined, trimmed according to quality score, and checked for chimeras. Sequences were assigned to de novo OTUs (operational taxonomic units) using uclust (50) to search sequences against the Greengenes database (2014 version), and were assigned if the sequence matched the database at 97% similarity or greater. If a read did not match a database sequence, it was considered unassigned. Taxonomy was assigned at the family level based on the Greengenes matching sequence. The genera Geobacillus, Rhodothermus, and Rhodocyclaceae were considered to be contaminants and were filtered out from the results. Table S1 includes the sequence abundances of the S. aureus family Staphylococcaceae, and the S. maltophilia family Xanthomonadaceae (the main organism with partly overlapping fatty acid profiles).
